Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

29 Jul 2014
Price Change (% chg)

$0.29 (+1.30%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for EBS


Emergent BioSolutions Inc. is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. The Company operates in two divisions: BioDefense Division and... (more)


Beta: 1.05
Market Cap (Mil.): $833.15
Shares Outstanding (Mil.): 37.41
Dividend: --
Yield (%): --


  EBS Industry Sector
P/E (TTM): 43.79 35.65 36.07
EPS (TTM): 0.51 -- --
ROI: 3.02 18.91 18.18
ROE: 4.15 19.67 19.05
Search Stocks

Biotech stocks rout beginning to reveal pockets of value

NEW YORK - Predicting when the bear market in biotech stocks will hit bottom is a hazardous prospect, but one gauge that factors in the rapid profit growth estimates for many of these companies suggests several are starting to look attractive.

16 Apr 2014


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks